Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bradykinin | 7 | 2003 | 157 | 0.530 |
Why?
|
| Blood Pressure | 21 | 2001 | 1451 | 0.440 |
Why?
|
| Propranolol | 15 | 1989 | 103 | 0.390 |
Why?
|
| Kinins | 5 | 1995 | 109 | 0.380 |
Why?
|
| Kallikreins | 6 | 1995 | 323 | 0.350 |
Why?
|
| Hypertension | 6 | 2003 | 1535 | 0.270 |
Why?
|
| Medulla Oblongata | 3 | 1995 | 19 | 0.230 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2003 | 40 | 0.220 |
Why?
|
| Brain | 4 | 2003 | 2176 | 0.220 |
Why?
|
| Norepinephrine | 12 | 1988 | 276 | 0.200 |
Why?
|
| Rats, Inbred WKY | 6 | 2003 | 48 | 0.180 |
Why?
|
| Rats, Inbred SHR | 6 | 2003 | 95 | 0.180 |
Why?
|
| Heart Rate | 17 | 2001 | 568 | 0.170 |
Why?
|
| Neurons | 1 | 2003 | 881 | 0.150 |
Why?
|
| Vagus Nerve | 5 | 2003 | 90 | 0.140 |
Why?
|
| Rats | 11 | 2003 | 5300 | 0.140 |
Why?
|
| Brain Chemistry | 3 | 1992 | 173 | 0.140 |
Why?
|
| Dogs | 19 | 1989 | 490 | 0.130 |
Why?
|
| Animals | 35 | 2003 | 20881 | 0.130 |
Why?
|
| Receptors, Neurotransmitter | 2 | 1992 | 31 | 0.130 |
Why?
|
| Renin | 8 | 1983 | 96 | 0.120 |
Why?
|
| Receptors, Bradykinin | 3 | 2003 | 50 | 0.110 |
Why?
|
| Iodine Radioisotopes | 3 | 2003 | 119 | 0.090 |
Why?
|
| Radioimmunoassay | 4 | 2002 | 164 | 0.090 |
Why?
|
| Atenolol | 1 | 1989 | 20 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2002 | 483 | 0.080 |
Why?
|
| Autoradiography | 2 | 2003 | 94 | 0.080 |
Why?
|
| Radioligand Assay | 2 | 2003 | 109 | 0.080 |
Why?
|
| Ferricyanides | 1 | 1987 | 4 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 16 | 0.070 |
Why?
|
| Nitroprusside | 1 | 1987 | 42 | 0.070 |
Why?
|
| Injections, Intraventricular | 4 | 1989 | 50 | 0.060 |
Why?
|
| Binding Sites | 2 | 2003 | 631 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 1989 | 498 | 0.060 |
Why?
|
| Propylamines | 2 | 1982 | 22 | 0.060 |
Why?
|
| Bee Venoms | 1 | 1984 | 2 | 0.060 |
Why?
|
| Melitten | 1 | 1984 | 2 | 0.060 |
Why?
|
| Male | 19 | 2003 | 37321 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2002 | 2083 | 0.060 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2003 | 1 | 0.060 |
Why?
|
| Area Postrema | 1 | 2003 | 2 | 0.060 |
Why?
|
| Solitary Nucleus | 1 | 2003 | 3 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 1984 | 36 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 165 | 0.060 |
Why?
|
| Ganglionic Stimulants | 1 | 1982 | 15 | 0.050 |
Why?
|
| Shock, Septic | 2 | 2001 | 101 | 0.050 |
Why?
|
| Clonidine | 2 | 1994 | 66 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 371 | 0.050 |
Why?
|
| Hemodynamics | 6 | 1982 | 705 | 0.040 |
Why?
|
| Heart | 3 | 1982 | 850 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 455 | 0.040 |
Why?
|
| Chromatography, Gas | 3 | 1976 | 31 | 0.040 |
Why?
|
| Microinjections | 2 | 1995 | 130 | 0.040 |
Why?
|
| Phenylephrine | 3 | 2001 | 61 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.030 |
Why?
|
| Anticonvulsants | 2 | 1977 | 223 | 0.030 |
Why?
|
| Electric Stimulation | 3 | 1987 | 218 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 1978 | 807 | 0.030 |
Why?
|
| Time Factors | 8 | 1985 | 4655 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1989 | 420 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1989 | 215 | 0.030 |
Why?
|
| Species Specificity | 1 | 1995 | 303 | 0.030 |
Why?
|
| Glutamates | 1 | 1994 | 41 | 0.030 |
Why?
|
| Desoxycorticosterone | 1 | 1993 | 41 | 0.030 |
Why?
|
| Heart Failure | 1 | 1982 | 1180 | 0.030 |
Why?
|
| Reserpine | 3 | 1988 | 24 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1993 | 136 | 0.030 |
Why?
|
| Tyramine | 3 | 1988 | 16 | 0.030 |
Why?
|
| Central Nervous System | 2 | 1989 | 107 | 0.030 |
Why?
|
| Stereoisomerism | 2 | 1989 | 169 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1992 | 124 | 0.030 |
Why?
|
| Sympatholytics | 1 | 1971 | 11 | 0.020 |
Why?
|
| Receptors, Drug | 1 | 1971 | 31 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1971 | 37 | 0.020 |
Why?
|
| Perfusion | 3 | 1985 | 131 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1994 | 332 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 1971 | 85 | 0.020 |
Why?
|
| Homeostasis | 1 | 1992 | 291 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2002 | 317 | 0.020 |
Why?
|
| Catecholamines | 1 | 1969 | 73 | 0.020 |
Why?
|
| Aging | 1 | 1995 | 911 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 532 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1987 | 31 | 0.020 |
Why?
|
| Denervation | 3 | 1979 | 23 | 0.020 |
Why?
|
| Female | 12 | 1989 | 38074 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1989 | 282 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1987 | 334 | 0.020 |
Why?
|
| Muscle Contraction | 2 | 2001 | 210 | 0.020 |
Why?
|
| Kidney | 2 | 1982 | 945 | 0.020 |
Why?
|
| Vasodilation | 2 | 1982 | 85 | 0.020 |
Why?
|
| Oxygen | 1 | 1967 | 386 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 1984 | 15 | 0.020 |
Why?
|
| Brain Stem | 1 | 1984 | 46 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 1984 | 23 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1984 | 53 | 0.010 |
Why?
|
| Isoproterenol | 2 | 1982 | 163 | 0.010 |
Why?
|
| Myocardial Contraction | 2 | 1982 | 383 | 0.010 |
Why?
|
| Aprotinin | 1 | 1984 | 55 | 0.010 |
Why?
|
| Body Weight | 2 | 1983 | 554 | 0.010 |
Why?
|
| Adrenergic Fibers | 1 | 1983 | 4 | 0.010 |
Why?
|
| Glycols | 2 | 1974 | 9 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 1983 | 15 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 765 | 0.010 |
Why?
|
| Ouabain | 1 | 1982 | 32 | 0.010 |
Why?
|
| Natriuresis | 1 | 1982 | 13 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1982 | 42 | 0.010 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 1982 | 2 | 0.010 |
Why?
|
| Myocardium | 2 | 1977 | 1204 | 0.010 |
Why?
|
| Furosemide | 1 | 1982 | 45 | 0.010 |
Why?
|
| Kinetics | 1 | 1984 | 1047 | 0.010 |
Why?
|
| Prostaglandins E | 2 | 1983 | 54 | 0.010 |
Why?
|
| Strychnine | 3 | 1977 | 14 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1984 | 219 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 289 | 0.010 |
Why?
|
| Isomerism | 1 | 1981 | 63 | 0.010 |
Why?
|
| Indomethacin | 2 | 1982 | 107 | 0.010 |
Why?
|
| Creatine Kinase | 2 | 1978 | 46 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 316 | 0.010 |
Why?
|
| Phenoxybenzamine | 2 | 1971 | 7 | 0.010 |
Why?
|
| Mass Spectrometry | 3 | 1976 | 284 | 0.010 |
Why?
|
| Mice | 5 | 1989 | 8474 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2001 | 107 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1982 | 738 | 0.010 |
Why?
|
| Cisterna Magna | 1 | 1979 | 3 | 0.010 |
Why?
|
| Lidocaine | 1 | 1979 | 36 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 211 | 0.010 |
Why?
|
| Injections | 1 | 1979 | 119 | 0.010 |
Why?
|
| Vagotomy | 2 | 1969 | 9 | 0.010 |
Why?
|
| Bartter Syndrome | 1 | 1977 | 2 | 0.010 |
Why?
|
| Hyperaldosteronism | 1 | 1977 | 5 | 0.010 |
Why?
|
| Hexamethonium Compounds | 3 | 1974 | 3 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2673 | 0.010 |
Why?
|
| Pentylenetetrazole | 1 | 1977 | 10 | 0.010 |
Why?
|
| Electroshock | 1 | 1977 | 36 | 0.010 |
Why?
|
| Perhexiline | 1 | 1977 | 1 | 0.010 |
Why?
|
| Oxprenolol | 1 | 1976 | 1 | 0.010 |
Why?
|
| Trifluoroacetic Acid | 1 | 1976 | 1 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1976 | 62 | 0.010 |
Why?
|
| Chemistry | 1 | 1976 | 45 | 0.010 |
Why?
|
| Piperidines | 1 | 1977 | 123 | 0.010 |
Why?
|
| Bradykinin Receptor Antagonists | 1 | 1995 | 20 | 0.010 |
Why?
|
| Solvents | 1 | 1976 | 109 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 1995 | 75 | 0.010 |
Why?
|
| Posture | 3 | 1983 | 107 | 0.010 |
Why?
|
| Hindlimb | 2 | 1974 | 38 | 0.010 |
Why?
|
| Isotopes | 1 | 1974 | 15 | 0.010 |
Why?
|
| Nortriptyline | 1 | 1974 | 28 | 0.010 |
Why?
|
| Seizures | 2 | 1974 | 279 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1974 | 101 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1977 | 258 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 1981 | 189 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1971 | 68 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1971 | 32 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1969 | 396 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1971 | 117 | 0.010 |
Why?
|
| Methyldopa | 1 | 1969 | 4 | 0.010 |
Why?
|
| Sodium | 2 | 1983 | 161 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1983 | 1745 | 0.010 |
Why?
|
| Pressoreceptors | 2 | 1984 | 15 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1969 | 13 | 0.010 |
Why?
|
| Histidine | 1 | 1969 | 17 | 0.010 |
Why?
|
| Histamine | 1 | 1969 | 52 | 0.010 |
Why?
|
| Tryptophan | 1 | 1969 | 65 | 0.010 |
Why?
|
| Humans | 8 | 2002 | 68618 | 0.010 |
Why?
|
| Serotonin | 1 | 1969 | 144 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1969 | 139 | 0.000 |
Why?
|
| Endotoxins | 1 | 1968 | 76 | 0.000 |
Why?
|
| Electrocardiography | 2 | 1983 | 601 | 0.000 |
Why?
|
| Splenectomy | 1 | 1967 | 40 | 0.000 |
Why?
|
| Dopamine | 1 | 1969 | 474 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1968 | 291 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1967 | 222 | 0.000 |
Why?
|
| Glucose | 1 | 1967 | 307 | 0.000 |
Why?
|
| Biotransformation | 2 | 1974 | 69 | 0.000 |
Why?
|
| Prazosin | 1 | 1983 | 10 | 0.000 |
Why?
|
| Vasoconstriction | 1 | 1983 | 81 | 0.000 |
Why?
|
| Hemoglobinometry | 1 | 1983 | 5 | 0.000 |
Why?
|
| Hematocrit | 1 | 1983 | 70 | 0.000 |
Why?
|
| Secretin | 1 | 1982 | 18 | 0.000 |
Why?
|
| Body Height | 1 | 1983 | 67 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1982 | 49 | 0.000 |
Why?
|
| Potassium | 1 | 1983 | 168 | 0.000 |
Why?
|
| Epoprostenol | 1 | 1982 | 71 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1984 | 324 | 0.000 |
Why?
|
| Creatinine | 1 | 1983 | 243 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1981 | 127 | 0.000 |
Why?
|
| Solubility | 1 | 1981 | 134 | 0.000 |
Why?
|
| Exercise Test | 1 | 1983 | 242 | 0.000 |
Why?
|
| Rabbits | 1 | 1981 | 509 | 0.000 |
Why?
|
| Adolescent | 2 | 1984 | 8912 | 0.000 |
Why?
|
| Behavior, Animal | 2 | 1974 | 470 | 0.000 |
Why?
|
| Child | 2 | 1983 | 6405 | 0.000 |
Why?
|
| Adult | 3 | 1984 | 21403 | 0.000 |
Why?
|
| Aldosterone | 1 | 1977 | 51 | 0.000 |
Why?
|
| Angiotensin II | 1 | 1977 | 220 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1977 | 239 | 0.000 |
Why?
|
| Ganglionic Blockers | 1 | 1974 | 2 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 57 | 0.000 |
Why?
|
| Diphenhydramine | 1 | 1974 | 13 | 0.000 |
Why?
|
| Atropine | 1 | 1974 | 29 | 0.000 |
Why?
|
| Computers | 1 | 1974 | 63 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1977 | 313 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1974 | 168 | 0.000 |
Why?
|
| Paralysis | 1 | 1974 | 35 | 0.000 |
Why?
|
| Mephenesin | 1 | 1973 | 1 | 0.000 |
Why?
|
| Chloralose | 1 | 1970 | 1 | 0.000 |
Why?
|
| Ganglia, Autonomic | 1 | 1970 | 10 | 0.000 |
Why?
|
| Chemoreceptor Cells | 1 | 1970 | 5 | 0.000 |
Why?
|
| Nerve Endings | 1 | 1970 | 14 | 0.000 |
Why?
|
| Carotid Sinus | 1 | 1970 | 5 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1970 | 24 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1970 | 46 | 0.000 |
Why?
|
| Methods | 1 | 1970 | 156 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1970 | 133 | 0.000 |
Why?
|
| Epinephrine | 1 | 1970 | 103 | 0.000 |
Why?
|
| Motor Activity | 1 | 1974 | 621 | 0.000 |
Why?
|
| Morphine | 1 | 1970 | 76 | 0.000 |
Why?
|
| Middle Aged | 2 | 1983 | 21147 | 0.000 |
Why?
|
| Research Design | 1 | 1974 | 729 | 0.000 |
Why?
|
| Placebos | 1 | 1969 | 195 | 0.000 |
Why?
|
| Anesthesia | 1 | 1970 | 120 | 0.000 |
Why?
|
| Aged | 1 | 1984 | 14862 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1968 | 368 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1969 | 848 | 0.000 |
Why?
|